Agrisera High-Quality Polyclonal and Monoclonal Antibody Services

Agrisera is a Swedish company which specialises in polyclonal and monoclonal antibody production. We take pride in our high service level and our antibodies that really work. We have been in business for nearly 30 years and have close collaboration with research groups and pharmaceutical companies around the globe. Agrisera follows strict quality guidelines and is approved by National Institutes of Health (NIH).

Monoclonal and polyclonal custom made antibodies

Agrisera offer a complete range of services for the production of custom made antibodies, both monoclonals and polyclonals. We can assist in designing or producing the antigen, raising the antibody all the way to a purified and labelled antibody.

Cell fusion developed monoclonals

We have longstanding experience in developing monoclonals, including cell fusion and hybridoma selection as well as scale-up of production using cell cultures. Our antibody shop offers a number of exclusive antibodies produced in collaboration with leading research groups, e.g. Alzheimer’s research antibodies specific to amyloid beta oligomers.

Custom made polyclonals

Agrisera has over the years produced polyclonal antibodies against several thousand different antigens. Custom made polyclonals are produced in rabbit, goat, hen, rat and mice. Our immunization programs are optimised to obtain antibodies of high titre and specificity. We are always willing to discuss different demands regarding the length of the program, antigen doses and administration.

Antigens and peptide synthesized design

Peptides can be designed and synthesized according to your requirements. Agrisera offers a complete service in this area and has longstanding experience in selecting peptides that work in specific applications. We also offer recombinant production of large peptides for immunisation.

Purification and antibody labelling

We perform affinity purification of IgG, IgM and IgY for applications such as immunoprecipitation, immunohistochemistry and antibody labelling. Labelling of antibodies with enzymes for use in ELISA and other immunochemical techniques is performed according to client needs.

Immunogenicity studies

Agrisera also performs immunogenicity studies for pharmaceutical companies. The studies are conducted following strict secrecy and ethical guidelines.

All off-the-shelf antibodies from Agrisera are accompanied with full documentation including instructions of use. Agrisera is approved by the National Institute of Health. The Agrisera NIH assurance number is; A5783-01.

Sendai virus for R&D and drug production

Since 1980 Agrisera have produced Sendai virus, which is used by drug companies for R&D and drug production. The virus production has been carried out in accordance with ever-increasing demands from the drug industry. For more information please contact us.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

Unique Monoclonal Antibody for Alzheimer’s Disease

Agrisera has released a unique monoclonal antibody for Alzheimer's disease, the Amyloid beta oligomer-specific monoclonal antibody (OMAB), a highly selective amylodi beta oligomers, monclonal antibody. It was recently published on PloS ONE: Lindhagen-Persson et al. (2010). 'Amyloid-ß ol

Address
Agrisera AB

Agrisera Images

Products and Services

Video

White Papers

Press Release

29 November 2010

Agrisera has released a unique monoclonal antibody for Alzheimer's disease, the Amyloid beta oligomer-specific monoclonal antibody (OMAB), a highly selective amylodi beta oligomers, monclonal antibody. It was recently published on PloS ONE: Lindhagen-Persson et al. (2010). 'Amyloid-ß ol

Read more
14 February 2010

Each antibody-antigen interaction has unique characteristics; a protocol that gives good results for one antibody-antigen pair might not be satisfactory for a second antibody, even on the same sample. The interaction of antisera with protein epitopes in Western blot depends on a number of factors

Read more
14 February 2010

Agrisera, a specialist in polyclonal and monoclonal antibody production, has introduced a new set of antibodies that detect human SOD1: SOD1 aa 03-20, superoxide dismutase 1, soluble SOD1 aa 100-115, superoxide dismutase 1, soluble SOD1 aa 131-153, superoxide di

Read more

Regional Offices

Agrisera AB

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.